One of the world's foremost biotechnology companies, Genzyme Corporation is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $3.2 billion and more than 9,000 employees in locations spanning the globe.
Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, provides an integrated resource of value-added technologies, custom manufacturing and strategic relationships focused in the lipid, peptide, amino acid derivative, and drug delivery markets.
